durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['nsclc', 'aegean', 'sclc']
the #oncoalerttoptweet day 3 #aacr23 tweet by our faculty impressive data from #aegean at #aacr23 from dr. john heymach and colleagues. this is the first of several phase iii peri-operative io studies in resectable nsclc combining 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨